Similar articles

• Insulin resistance in polycystic ovary syndrome.

  Prelevic GM. Prelevic GM. Curr Opin Obstet Gynecol. 1997 Jun;9(3):193-201. Curr Opin Obstet Gynecol. 1997. PMID: 9263704 Review.
• [Insulin resistance and polycystic ovary syndrome].

  Dewailly D, Cortet-Rudelli C, Nobels F, Henric B, Longelin C, Fossati P. Dewailly D, et al. Ann Endocrinol (Paris). 1992;53(1):1-7. Ann Endocrinol (Paris). 1992. PMID: 1444176 Review. French.
• Premature pubarche, ovarian hyperandrogenism, hyperinsulinism and the polycystic ovary syndrome: from a complex constellation to a simple sequence of prenatal onset.

  Ibáñez L, de Zegher F, Potau N. Ibáñez L, et al. J Endocrinol Invest. 1998 Oct;21(9):558-66. doi: 10.1007/BF03350781. J Endocrinol Invest. 1998. PMID: 9856410 Review.
• Polycystic ovarian syndrome: the next cardiovascular dilemma in women?

  Srikanthan P, Korenman S, Davis S. Srikanthan P, et al. Endocrinol Metab Clin North Am. 2006 Sep;35(3):611-31, x. doi: 10.1016/j.ecl.2006.05.001. Endocrinol Metab Clin North Am. 2006. PMID: 16959589 Review.
• [Hyperinsulinism and hyperandrogenism in polycystic ovarian disease].

  Shehadeh N, Ish-Shalom S. Shehadeh N, et al. Harefuah. 1990 Jun 15;118(12):712-3. Harefuah. 1990. PMID: 2201617 Review. Hebrew. No abstract available.